Lentivirus News and Research

RSS
Lentivirus is a genus of slow viruses of the Retroviridae family, characterized by a long incubation period.
Canadian pilot study uses gene therapy to successfully treat patients with Fabry disease

Canadian pilot study uses gene therapy to successfully treat patients with Fabry disease

New mouse model of SARS-CoV-2 infection reflects features of human infection

New mouse model of SARS-CoV-2 infection reflects features of human infection

New contraceptive gel contains spermicidal, anti-viral, libido-enhancing agents in one formulation

New contraceptive gel contains spermicidal, anti-viral, libido-enhancing agents in one formulation

New drug screening platform identifies inhibitors of SARS-CoV-2

New drug screening platform identifies inhibitors of SARS-CoV-2

Discovery of SARS-CoV-2 neutralizing antibodies from a naïve human Ab library

Discovery of SARS-CoV-2 neutralizing antibodies from a naïve human Ab library

Tetherin downregulation by SARS-CoV-2 enhances viral spread

Tetherin downregulation by SARS-CoV-2 enhances viral spread

Could engineered red blood cells be an effective antiviral against SARS-CoV-2?

Could engineered red blood cells be an effective antiviral against SARS-CoV-2?

A common compound in mouthwashes found to inhibit SARS-CoV-2 in vitro

A common compound in mouthwashes found to inhibit SARS-CoV-2 in vitro

Rapid point-of-care lateral flow assay to assess the neutralizing activity of plasma against SARS-CoV-2

Rapid point-of-care lateral flow assay to assess the neutralizing activity of plasma against SARS-CoV-2

SARS-CoV-2 spike protein mediates acute lung pathology in mice

SARS-CoV-2 spike protein mediates acute lung pathology in mice

Different SARS-CoV-2 neutralization assays are reliable and concordant for antibody monitoring

Different SARS-CoV-2 neutralization assays are reliable and concordant for antibody monitoring

Nanoparticles with neutralizing antibodies can inactivate SARS-CoV-2

Nanoparticles with neutralizing antibodies can inactivate SARS-CoV-2

Males may have higher but more transient SARS-CoV-2 immunity than females post-infection

Males may have higher but more transient SARS-CoV-2 immunity than females post-infection

Researchers identify antibodies that prevent SARS-CoV-2 from infecting human cells

Researchers identify antibodies that prevent SARS-CoV-2 from infecting human cells

Rapid generation of divergent synthetic antibodies against SARS-CoV-2 in a cell-free engineering platform

Rapid generation of divergent synthetic antibodies against SARS-CoV-2 in a cell-free engineering platform

Furin cleavage site and D614G on SARS-CoV-2 spike evolved to balance infectivity, stability, cytopathicity

Furin cleavage site and D614G on SARS-CoV-2 spike evolved to balance infectivity, stability, cytopathicity

Engineered, high-affinity ACE2 receptors neutralize SARS-CoV-2

Engineered, high-affinity ACE2 receptors neutralize SARS-CoV-2

SARS-CoV-2 lured away and trapped by a new decoy version of ACE2

SARS-CoV-2 lured away and trapped by a new decoy version of ACE2

Iota-carrageenan from red seaweed inhibits SARS-CoV-2 in laboratory conditions

Iota-carrageenan from red seaweed inhibits SARS-CoV-2 in laboratory conditions

Research could lead to more efficient cellular immunotherapies for advanced cancers

Research could lead to more efficient cellular immunotherapies for advanced cancers